Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication February 6, 2018
- Accepted for publication May 31, 2018
- Published online December 3, 2018.
Article Versions
- previous version (June 29, 2018 - 11:05).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Jaeyeon Choi1,
- Wissam Beaino2,3,
- Ronald J. Fecek4,
- Kellsye P.L. Fabian5,
- Charles M. Laymon2,
- Brenda F. Kurland6,
- Walter J. Storkus1,4,5 and
- Carolyn J. Anderson1,2,7,8
- 1Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania
- 2Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania
- 3VU University Medical Center, Department of Radiology and Nuclear Medicine, Amsterdam, The Netherlands
- 4Department of Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania
- 5Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania
- 6Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania
- 7Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; and
- 8Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania
- For correspondence or reprints contact: Carolyn J. Anderson, Department of Medicine, University of Pittsburgh, 3501 Fifth Ave., Room 10020, Pittsburgh, PA 15260. E-mail: andersoncj{at}upmc.edu
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Combined Targeted Radiopharmaceutical Therapy and Immune Checkpoint Blockade: From Preclinical Advances to the Clinic
- Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy
- Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade
- CUB domain containing protein 1 (CDPC1) is a target for radioligand therapy in castration resistant prostate cancer
- Advances in Receptor-Targeted Radiolabeled Peptides for Melanoma Imaging and Therapy
- Immune-Checkpoint Blockade Enhances 225Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer
- Molecular Imaging of Very Late Antigen-4 in Acute Lung Injury
- Cell Adhesion Molecules in Plasticity and Metastasis
- Combination Strategies to Improve Targeted Radionuclide Therapy